Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Joint Bone Spine|November 6, 2022
Autoimmune epithelitis in primary Sjögren's syndromeEmiko Desvaux, Jacques-Olivier PersEJNMMI Research|December 22, 2018
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivoEmiko Desvaux, Alan Courteau, Pierre-Simon Bellaye, et al.Expert Review of Clinical Immunology|November 29, 2021
Model-based computational precision medicine to develop combination therapies for autoimmune diseasesEmiko Desvaux, Audrey Aussy, Sandra Hubert, et al.Expert Opinion on Drug Discovery|July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platformMickaël Guedj, Jack Swindle, Antoine Hamon, et al.Plos One|July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.Journal of Autoimmunity|December 19, 2023
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndromeEmiko Desvaux, Patrice Hemon, Perrine Soret, et al.Journal of Translational Autoimmunity|March 22, 2021
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseasesFanny Duguet, Céline Ortega-Ferreira, Benjamin Fould, et al.Iscience|February 10, 2025
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupusVincent Hurez, Glenn Gauderat, Perrine Soret, et al.Clinical Immunology (Orlando, Fla.)|May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's diseaseCheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.Nature Communications|August 31, 2023
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosisCéline Ortega-Ferreira, Perrine Soret, Gautier Robin, et al.Pageof 2